Skip to main content
Erschienen in: Pituitary 3/2012

01.09.2012

Growth hormone and proopiomelanocortin are targeted by autoantibodies in a patient with biopsy-proven IgG4-related hypophysitis

verfasst von: M. A. Landek-Salgado, P. Leporati, I. Lupi, A. Geis, P. Caturegli

Erschienen in: Pituitary | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Hypophysitis is a chronic inflammation of the pituitary gland often caused by autoimmunity. Among the autoimmune diseases it is one of the few where the autoantigens remain to be identified. The goal of the paper was to characterize the antigenic profile in a previously reported patient with IgG4-related hypophysitis. Immunofluorescence and immunoblotting were performed to detect antibodies to human pituitary proteins. The proteins recognized by western blotting were then submitted to mass spectrometry for sequencing. The patient’s autoantibodies recognized two unique bands around 40 and 30 kDa on immunoblotting. Sequencing revealed one peptide from proopiomelanocortin in the 40 kDa band and four peptides from growth hormone in the 30 kDa band. This work represents the first antigenic profile in IgG4-related hypophysitis, and the first recognition of proopiomelanocortin as a possible pituitary autoantigen. In addition, the work supports previous suggestions of growth hormone as a pituitary autoantigen. Further studies are needed to prove the pathogenicity and diagnostic utility of these two pituitary proteins.
Literatur
1.
Zurück zum Zitat Caturegli P, Lupi I, Landek-Salgado M, Kimura H, Rose NR (2008) Pituitary autoimmunity: 30 years later. Autoimmun Rev 7:631–637PubMedCrossRef Caturegli P, Lupi I, Landek-Salgado M, Kimura H, Rose NR (2008) Pituitary autoimmunity: 30 years later. Autoimmun Rev 7:631–637PubMedCrossRef
2.
Zurück zum Zitat Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR (2005) Autoimmune hypophysitis. Endocr Rev 26:599–614PubMedCrossRef Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR (2005) Autoimmune hypophysitis. Endocr Rev 26:599–614PubMedCrossRef
3.
Zurück zum Zitat Aste L, Bellinzona M, Meleddu V, Farci G, Manieli C, Godano U (2010) Xanthomatous hypophysitis mimicking a pituitary adenoma: case report and review of the literature. J Oncol 2010:195323. doi:10.1155/2010/195323 PubMedCrossRef Aste L, Bellinzona M, Meleddu V, Farci G, Manieli C, Godano U (2010) Xanthomatous hypophysitis mimicking a pituitary adenoma: case report and review of the literature. J Oncol 2010:195323. doi:10.​1155/​2010/​195323 PubMedCrossRef
4.
Zurück zum Zitat Gutenberg A, Caturegli P, Metz I, Martinez R, Mohr A, Bruck W, Rohde V (2011) Necrotizing infundibulo-hypophysitis: an entity too rare to be true? Pituitary. doi:10.1007/s11102-011-0307-2 Gutenberg A, Caturegli P, Metz I, Martinez R, Mohr A, Bruck W, Rohde V (2011) Necrotizing infundibulo-hypophysitis: an entity too rare to be true? Pituitary. doi:10.​1007/​s11102-011-0307-2
5.
Zurück zum Zitat Leporati P, Landek-Salgado M, Lupi I, Chiovato L, Caturegli P (2011) IgG4-related autoimmune hypophysitis: an emerging clinicopathological entity. J Clin Endocrinol Metab 96(7):1971–1980CrossRef Leporati P, Landek-Salgado M, Lupi I, Chiovato L, Caturegli P (2011) IgG4-related autoimmune hypophysitis: an emerging clinicopathological entity. J Clin Endocrinol Metab 96(7):1971–1980CrossRef
6.
Zurück zum Zitat Shimatsu A, Oki Y, Fujisawa I, Sano T (2009) Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entity. Endocr J 56(9):1033–1041PubMedCrossRef Shimatsu A, Oki Y, Fujisawa I, Sano T (2009) Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entity. Endocr J 56(9):1033–1041PubMedCrossRef
8.
Zurück zum Zitat Frulloni L, Lunardi C, Simone R, Dolcino M, Scattolini C, Falconi M, Benini L, Vantini I, Corrocher R, Puccetti A (2009) Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med 361(22):2135–2142. doi:10.1056/NEJMoa0903068 PubMedCrossRef Frulloni L, Lunardi C, Simone R, Dolcino M, Scattolini C, Falconi M, Benini L, Vantini I, Corrocher R, Puccetti A (2009) Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med 361(22):2135–2142. doi:10.​1056/​NEJMoa0903068 PubMedCrossRef
9.
Zurück zum Zitat Caturegli P (2007) Autoimmune hypophysitis: an underestimated disease in search of its autoantigen(s). J Clin Endocrinol Metab 92(6):2038–2040PubMedCrossRef Caturegli P (2007) Autoimmune hypophysitis: an underestimated disease in search of its autoantigen(s). J Clin Endocrinol Metab 92(6):2038–2040PubMedCrossRef
10.
Zurück zum Zitat Lupi I, Broman KW, Tzou SC, Gutenberg A, Martino E, Caturegli P (2008) Novel autoantigens in autoimmune hypophysitis. Clin Endocrinol 69:269–278CrossRef Lupi I, Broman KW, Tzou SC, Gutenberg A, Martino E, Caturegli P (2008) Novel autoantigens in autoimmune hypophysitis. Clin Endocrinol 69:269–278CrossRef
11.
Zurück zum Zitat Crock PA (1998) Cytosolic autoantigens in lymphocytic hypophysitis. J Clin Endocrinol Metab 83(2):609–618PubMedCrossRef Crock PA (1998) Cytosolic autoantigens in lymphocytic hypophysitis. J Clin Endocrinol Metab 83(2):609–618PubMedCrossRef
12.
Zurück zum Zitat Takao T, Nanamiya W, Matsumoto R, Asaba K, Okabayashi T, Hashimoto K (2001) Antipituitary antibodies in patients with lymphocytic hypophysitis. Horm Res 55:288–292PubMedCrossRef Takao T, Nanamiya W, Matsumoto R, Asaba K, Okabayashi T, Hashimoto K (2001) Antipituitary antibodies in patients with lymphocytic hypophysitis. Horm Res 55:288–292PubMedCrossRef
13.
Zurück zum Zitat Tanaka S, Tatsumi KI, Kimura M, Takano T, Murakami Y, Takao T, Hashimoto K, Kato Y, Amino N (2002) Detection of autoantibodies against the pituitary-specific proteins in patients with lymphocytic hypophysitis. Eur J Endocrinol 147:767–775PubMedCrossRef Tanaka S, Tatsumi KI, Kimura M, Takano T, Murakami Y, Takao T, Hashimoto K, Kato Y, Amino N (2002) Detection of autoantibodies against the pituitary-specific proteins in patients with lymphocytic hypophysitis. Eur J Endocrinol 147:767–775PubMedCrossRef
14.
Zurück zum Zitat Bensing S, Hulting AL, Hoog A, Ericson K, Kampe O (2007) Lymphocytic hypophysitis: report of two biopsy-proven cases and one suspected case with pituitary autoantibodies. J Endocrinol Invest 30(2):153–162PubMed Bensing S, Hulting AL, Hoog A, Ericson K, Kampe O (2007) Lymphocytic hypophysitis: report of two biopsy-proven cases and one suspected case with pituitary autoantibodies. J Endocrinol Invest 30(2):153–162PubMed
15.
Zurück zum Zitat Yamamoto M, Iguchi G, Takeno R, Okimura Y, Sano T, Takahashi M, Nishizawa H, Handayaningshi AE, Fukuoka H, Tobita M, Saitoh T, Tojo K, Mokubo A, Morinobu A, Iida K, Kaji H, Seino S, Chihara K, Takahashi Y (2011) Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans. J Clin Invest 121(1):113–119. doi:10.1172/JCI44073 PubMedCrossRef Yamamoto M, Iguchi G, Takeno R, Okimura Y, Sano T, Takahashi M, Nishizawa H, Handayaningshi AE, Fukuoka H, Tobita M, Saitoh T, Tojo K, Mokubo A, Morinobu A, Iida K, Kaji H, Seino S, Chihara K, Takahashi Y (2011) Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans. J Clin Invest 121(1):113–119. doi:10.​1172/​JCI44073 PubMedCrossRef
16.
Zurück zum Zitat Crock P, Salvi M, Miller A, Wall J, Guyda H (1993) Detection of anti-pituitary autoantibodies by immunoblotting. J Immunol Methods 162:31–40PubMedCrossRef Crock P, Salvi M, Miller A, Wall J, Guyda H (1993) Detection of anti-pituitary autoantibodies by immunoblotting. J Immunol Methods 162:31–40PubMedCrossRef
17.
Zurück zum Zitat Glück M, Scherbaum WA (1990) Substrate specificity for the detection of autoantibodies to anterior pituitary cells in human sera. Horm Metab Res 22:541–545PubMedCrossRef Glück M, Scherbaum WA (1990) Substrate specificity for the detection of autoantibodies to anterior pituitary cells in human sera. Horm Metab Res 22:541–545PubMedCrossRef
18.
Zurück zum Zitat Pouplard A, Bottazzo GF, Doniach D, Roitt IM (1976) Binding of human immunoglobulins to pituitary ACTH cells. Nature 261(5556):142–144PubMedCrossRef Pouplard A, Bottazzo GF, Doniach D, Roitt IM (1976) Binding of human immunoglobulins to pituitary ACTH cells. Nature 261(5556):142–144PubMedCrossRef
21.
Zurück zum Zitat Charrier J, Martal J (1988) Growth hormones. 1. Polymorphism (minireview). Reprod Nutr Dev 28(4A):857–887 Charrier J, Martal J (1988) Growth hormones. 1. Polymorphism (minireview). Reprod Nutr Dev 28(4A):857–887
23.
Zurück zum Zitat Bellastella G, Rotondi M, Pane E, Dello IA, Pirali B, Dalla Mora L, Falorni A, Sinisi AA, Bizzarro A, Colao A, Chiovato L, De Bellis A (2010) Predictive role of the immunostaining pattern of immunofluorescence and the titers of antipituitary antibodies at presentation for the occurrence of autoimmune hypopituitarism in patients with autoimmune polyendocrine syndromes over a five-year follow-up. J Clin Endocrinol Metab. doi:10.1210/jc.2010-0551 Bellastella G, Rotondi M, Pane E, Dello IA, Pirali B, Dalla Mora L, Falorni A, Sinisi AA, Bizzarro A, Colao A, Chiovato L, De Bellis A (2010) Predictive role of the immunostaining pattern of immunofluorescence and the titers of antipituitary antibodies at presentation for the occurrence of autoimmune hypopituitarism in patients with autoimmune polyendocrine syndromes over a five-year follow-up. J Clin Endocrinol Metab. doi:10.​1210/​jc.​2010-0551
24.
Zurück zum Zitat De Bellis A, Bizzarro A, Conte M, Perrino S, Coronella C, Solimeno S, Sinisi AM, Stile LA, Pisano G, Bellastella A (2003) Antipituitary antibodies in adults with apparently idiopathic growth hormone deficiency and in adults with autoimmune endocrine diseases. J Clin Endocrinol Metab 88(2):650–654PubMedCrossRef De Bellis A, Bizzarro A, Conte M, Perrino S, Coronella C, Solimeno S, Sinisi AM, Stile LA, Pisano G, Bellastella A (2003) Antipituitary antibodies in adults with apparently idiopathic growth hormone deficiency and in adults with autoimmune endocrine diseases. J Clin Endocrinol Metab 88(2):650–654PubMedCrossRef
25.
Zurück zum Zitat Tzou SC, Lupi I, Landek M, Gutenberg A, Tzou YM, Kimura H, Pinna G, Rose NR, Caturegli P (2008) Autoimmune hypophysitis of SJL mice: clinical insights from a new animal model. Endocrinology 49(7):3461–3469CrossRef Tzou SC, Lupi I, Landek M, Gutenberg A, Tzou YM, Kimura H, Pinna G, Rose NR, Caturegli P (2008) Autoimmune hypophysitis of SJL mice: clinical insights from a new animal model. Endocrinology 49(7):3461–3469CrossRef
26.
Zurück zum Zitat Raffin-Sanson ML, de Keyzer Y, Bertagna X (2003) Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. Eur J Endocrinol 149(2):79–90PubMedCrossRef Raffin-Sanson ML, de Keyzer Y, Bertagna X (2003) Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. Eur J Endocrinol 149(2):79–90PubMedCrossRef
27.
Zurück zum Zitat Grigorakis SI, Anastasiou E, Dai K, Souvatzoglou A, Alevizaki M (2000) Three mRNA transcripts of the proopiomelanocortin gene in human placenta at term. Eur J Endocrinol 142(5):533–536PubMedCrossRef Grigorakis SI, Anastasiou E, Dai K, Souvatzoglou A, Alevizaki M (2000) Three mRNA transcripts of the proopiomelanocortin gene in human placenta at term. Eur J Endocrinol 142(5):533–536PubMedCrossRef
28.
Zurück zum Zitat Raffin-Sanson ML, Massias JF, Ankotche A, Coste J, de Keyzer Y, Oliver C, Dumont C, Cabrol D, Ferre F, Bertagna X (1999) High precursor level in maternal blood results from the alternate mode of proopiomelanocortin processing in human placenta. Clin Endocrinol (Oxf) 50(1):85–94CrossRef Raffin-Sanson ML, Massias JF, Ankotche A, Coste J, de Keyzer Y, Oliver C, Dumont C, Cabrol D, Ferre F, Bertagna X (1999) High precursor level in maternal blood results from the alternate mode of proopiomelanocortin processing in human placenta. Clin Endocrinol (Oxf) 50(1):85–94CrossRef
29.
Zurück zum Zitat Raffin-Sanson ML, Ferre F, Coste J, Oliver C, Cabrol D, Bertagna X (2000) Pro-opiomelanocortin in human pregnancy: evolution of maternal plasma levels, concentrations in cord blood, amniotic fluid and at the feto-maternal interface. Eur J Endocrinol 142(1):53–59PubMedCrossRef Raffin-Sanson ML, Ferre F, Coste J, Oliver C, Cabrol D, Bertagna X (2000) Pro-opiomelanocortin in human pregnancy: evolution of maternal plasma levels, concentrations in cord blood, amniotic fluid and at the feto-maternal interface. Eur J Endocrinol 142(1):53–59PubMedCrossRef
30.
Zurück zum Zitat Bourdelle-Hego MF, Dewailly D, Cappoen JP, Lingard-Leroy C, Fossati P (1985) Hypophysite du post partum, une ètiologie très souvent mécounnue d’hypopituitarism antérieur; à propos de 2 obsevations. Rev Franc Endocrinol Clin 26:99–104 Bourdelle-Hego MF, Dewailly D, Cappoen JP, Lingard-Leroy C, Fossati P (1985) Hypophysite du post partum, une ètiologie très souvent mécounnue d’hypopituitarism antérieur; à propos de 2 obsevations. Rev Franc Endocrinol Clin 26:99–104
31.
Zurück zum Zitat Sauter NP, Toni R, McLaughlin CD, Dyess EM, Kritzman J, Lechan RM (1990) Isolated adrenocorticotropin deficiency associated with an autoantibody to a corticotroph antigen that is not adrenocorticotropin or other proopiomelanocortin-derived peptides. J Clin Endocrinol Metab 70(5):1391–1397PubMedCrossRef Sauter NP, Toni R, McLaughlin CD, Dyess EM, Kritzman J, Lechan RM (1990) Isolated adrenocorticotropin deficiency associated with an autoantibody to a corticotroph antigen that is not adrenocorticotropin or other proopiomelanocortin-derived peptides. J Clin Endocrinol Metab 70(5):1391–1397PubMedCrossRef
32.
Zurück zum Zitat Bensing S, Kasperlik-Zaluska AA, Czarnocka B, Crock PA, Hulting A (2005) Autoantibodies against pituitary proteins in patients with adrenocorticotropin-deficiency. Eur J Clin Invest 35:126–132PubMedCrossRef Bensing S, Kasperlik-Zaluska AA, Czarnocka B, Crock PA, Hulting A (2005) Autoantibodies against pituitary proteins in patients with adrenocorticotropin-deficiency. Eur J Clin Invest 35:126–132PubMedCrossRef
33.
Zurück zum Zitat De Bellis A, Pane E, Bellastella G, Sinisi AA, Colella C, Giordano R, Giavoli C, Lania A, Ambrosio MR, Di Somma C, Zatelli MC, Arvat E, Colao A, Bizzarro A, Bellastella A (2011) Detection of anti-pituitary and anti-hypothalamus antibodies to investigate the role of pituitary or hypothalamic autoimmunity in patients with selective idiopathy hypopituitarism. Clin Endocrinol (Oxf). doi:10.1111/j.1365-2265.2011.04056.x De Bellis A, Pane E, Bellastella G, Sinisi AA, Colella C, Giordano R, Giavoli C, Lania A, Ambrosio MR, Di Somma C, Zatelli MC, Arvat E, Colao A, Bizzarro A, Bellastella A (2011) Detection of anti-pituitary and anti-hypothalamus antibodies to investigate the role of pituitary or hypothalamic autoimmunity in patients with selective idiopathy hypopituitarism. Clin Endocrinol (Oxf). doi:10.​1111/​j.​1365-2265.​2011.​04056.​x
Metadaten
Titel
Growth hormone and proopiomelanocortin are targeted by autoantibodies in a patient with biopsy-proven IgG4-related hypophysitis
verfasst von
M. A. Landek-Salgado
P. Leporati
I. Lupi
A. Geis
P. Caturegli
Publikationsdatum
01.09.2012
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 3/2012
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-011-0338-8

Weitere Artikel der Ausgabe 3/2012

Pituitary 3/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

RAS-Blocker bei Hyperkaliämie möglichst nicht sofort absetzen

14.05.2024 Hyperkaliämie Nachrichten

Bei ausgeprägter Nierenfunktionsstörung steigen unter der Einnahme von Renin-Angiotensin-System(RAS)-Hemmstoffen nicht selten die Serumkaliumspiegel. Was in diesem Fall zu tun ist, erklärte Prof. Jürgen Floege beim diesjährigen Allgemeinmedizin-Update-Seminar.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.